Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IQVIA Holdings Inc.

IQVIA Holdings Inc. (IQV) Stock Overview

Explore IQVIA Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

IQV●NYSE
HealthcareMedical - Diagnostics & Research
$259.82
$3.77(1.47%)
U.S. Market opens in 64h 55m

IQVIA Holdings Inc. (IQV)

Meyka AI Score

Z

Key Financials

Market Cap42.8B
P/E Ratio31.88
EPS (TTM)$12.13
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$235.61
3 Months$228.25
1 Year Target$204.78

IQV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of IQVIA Holdings Inc. (NYSE: IQV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IQVIA Holdings Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IQV on the NYSE shows an RSI of 71.42, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $204.78 for the NYSE listing.

Key metrics behind IQVIA Holdings Inc.'s NYSE-traded stock include a P/E ratio of 31.88 and a market capitalization of 42.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IQV on the NYSE.

Price Performance (NYSE: IQV)

1-Day Change
1.53%
5-Day Change
8.07%
1-Month Change
28.94%
3-Month Change
54.72%
6-Month Change
56.96%
Year-to-Date (YTD) Change
15.33%
1-Year Change
40.22%
3-Year Change
21.27%
5-Year Change
2.19%
All-Time (Max) Change
517.34%

Contact Information

https://www.iqvia.com
919 998 2000
2400 Ellis Road, Durham, NC, 27703

Company Facts

940,000 Employees
IPO DateMay 9, 2013
CountryUS
Actively Trading

Frequently Asked Questions